BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 1999;341:1882-1890. [PMID: 10601507 DOI: 10.1056/nejm199912163412503] [Cited by in Crossref: 1726] [Cited by in F6Publishing: 217] [Article Influence: 78.5] [Reference Citation Analysis]
Number Citing Articles
1 Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, Aguinaga L, Berger RD, Cuesta A, Daubert JP, Dubner S, Ellenbogen KA, Estes NA 3rd, Fenelon G, Garcia FC, Gasparini M, Haines DE, Healey JS, Hurtwitz JL, Keegan R, Kolb C, Kuck KH, Marinskis G, Martinelli M, McGuire M, Molina LG, Okumura K, Proclemer A, Russo AM, Singh JP, Swerdlow CD, Teo WS, Uribe W, Viskin S, Wang CC, Zhang S. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. J Arrhythm 2016;32:1-28. [PMID: 26949427 DOI: 10.1016/j.joa.2015.12.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 4.6] [Reference Citation Analysis]
2 Al-Khatib SM, Hafley G, Lee KL, Buxton AE. Relation between time from myocardial infarction to enrolment and patient outcomes in the Multicenter UnSustained Tachycardia Trial. Europace 2010;12:1112-8. [PMID: 20452992 DOI: 10.1093/europace/euq116] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Rao MP, Al-Khatib SM, Pokorney SD, She L, Romanov A, Nicolau JC, Lee KL, Carson P, Selzman CH, Stepinska J, Cleland JG, Tungsubutra W, Desvigne-Nickens PM, Sueta CA, Siepe M, Lang I, Feldman AM, Yii M, Rouleau JL, Velazquez EJ; STICH Trial Investigators. Sudden Cardiac Death in Patients With Ischemic Heart Failure Undergoing Coronary Artery Bypass Grafting: Results From the STICH Randomized Clinical Trial (Surgical Treatment for Ischemic Heart Failure). Circulation 2017;135:1136-44. [PMID: 28154006 DOI: 10.1161/CIRCULATIONAHA.116.026075] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Garfinkel A, Kim YH, Voroshilovsky O, Qu Z, Kil JR, Lee MH, Karagueuzian HS, Weiss JN, Chen PS. Preventing ventricular fibrillation by flattening cardiac restitution. Proc Natl Acad Sci U S A 2000;97:6061-6. [PMID: 10811880 DOI: 10.1073/pnas.090492697] [Cited by in Crossref: 404] [Cited by in F6Publishing: 281] [Article Influence: 19.2] [Reference Citation Analysis]
5 Hess PL, Al-Khatib SM, Han JY, Edwards R, Bardy GH, Bigger JT, Buxton A, Cappato R, Dorian P, Hallstrom A, Kadish AH, Kudenchuk PJ, Lee KL, Mark DB, Moss AJ, Steinman R, Inoue LY, Sanders G. Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials. Circ Cardiovasc Qual Outcomes 2015;8:179-86. [PMID: 25669833 DOI: 10.1161/CIRCOUTCOMES.114.001306] [Cited by in Crossref: 68] [Cited by in F6Publishing: 15] [Article Influence: 11.3] [Reference Citation Analysis]
6 Wolpert C, Kuschyk J, Aramin N, Spehl S, Streitner F, Süselbeck T, Schumacher B, Haase KK, Schimpf R, Borggrefe M. Incidence and electrophysiological characteristics of spontaneous ventricular tachyarrhythmias in high risk coronary patients and prophylactic implantation of a defibrillator. Heart 2004;90:667-71. [PMID: 15145875 DOI: 10.1136/hrt.2003.019042] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
7 Sukhija R, Mehta V, Leonardi M, Mehta JL. Implantable cardioverter defibrillators for prevention of sudden cardiac death. Clin Cardiol 2007;30:3-8. [PMID: 17262771 DOI: 10.1002/clc.20001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
8 Morgan JM, Cowan JC, Camm AJ, McComb JM. Sudden cardiac death: opportunities for prevention. Heart 2006;92:721-3. [PMID: 16159972 DOI: 10.1136/hrt.2005.073726] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
9 Bansal N, Szpiro A, Reynolds K, Smith DH, Magid DJ, Gurwitz JH, Masoudi F, Greenlee RT, Tabada GH, Sung SH, Dighe A, Go AS. Long-term Outcomes Associated With Implantable Cardioverter Defibrillator in Adults With Chronic Kidney Disease. JAMA Intern Med 2018;178:390-8. [PMID: 29404570 DOI: 10.1001/jamainternmed.2017.8462] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 11.5] [Reference Citation Analysis]
10 Seegers J, Conen D, Jung K, Bergau L, Dorenkamp M, Lüthje L, Sohns C, Sossalla ST, Fischer TH, Hasenfuss G, Friede T, Zabel M. Sex difference in appropriate shocks but not mortality during long-term follow-up in patients with implantable cardioverter-defibrillators. Europace 2016;18:1194-202. [PMID: 26622054 DOI: 10.1093/europace/euv361] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
11 van Welsenes GH, Borleffs CJ, van Rees JB, Atary JZ, Thijssen J, van der Wall EE, Schalij MJ. Improvements in 25 Years of Implantable Cardioverter Defibrillator Therapy. Neth Heart J 2011;19:24-30. [PMID: 21350585 DOI: 10.1007/s12471-010-0047-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
12 Sasano T, Kelemen K, Greener ID, Donahue JK. Ventricular tachycardia from the healed myocardial infarction scar: validation of an animal model and utility of gene therapy. Heart Rhythm 2009;6:S91-7. [PMID: 19631912 DOI: 10.1016/j.hrthm.2009.03.048] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
13 Zeitler EP, Al-Khatib SM, Friedman DJ, Han JY, Poole JE, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Dorian P, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Inoue LYT, Sanders GD. Predicting appropriate shocks in patients with heart failure: Patient level meta-analysis from SCD-HeFT and MADIT II. J Cardiovasc Electrophysiol 2017;28:1345-51. [PMID: 28744959 DOI: 10.1111/jce.13307] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
14 Kini V, Soufi MK, Deo R, Epstein AE, Bala R, Riley M, Groeneveld PW, Shalaby A, Dixit S. Appropriateness of primary prevention implantable cardioverter-defibrillators at the time of generator replacement: are indications still met? J Am Coll Cardiol 2014;63:2388-94. [PMID: 24727249 DOI: 10.1016/j.jacc.2014.03.025] [Cited by in Crossref: 99] [Cited by in F6Publishing: 64] [Article Influence: 14.1] [Reference Citation Analysis]
15 Nielsen OW, Hilden J, Hansen JF. Strong prognostic value of combining N-terminal atrial natriuretic peptide and ECG to predict death in heart patients from general practice. Heart 2001;86:218-9. [PMID: 11454848 DOI: 10.1136/heart.86.2.218] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
16 Abi-Samra F, Gutterman D. Cardiac contractility modulation: a novel approach for the treatment of heart failure. Heart Fail Rev 2016;21:645-60. [PMID: 27394714 DOI: 10.1007/s10741-016-9571-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 11.7] [Reference Citation Analysis]
17 Deyell MW, Krahn AD, Goldberger JJ. Sudden cardiac death risk stratification. Circ Res. 2015;116:1907-1918. [PMID: 26044247 DOI: 10.1161/circresaha.116.304493] [Cited by in Crossref: 61] [Cited by in F6Publishing: 13] [Article Influence: 10.2] [Reference Citation Analysis]
18 Torales JM, Centurión OA, Aquino NJ, Chávez CO, Alderete JF, Scavenius KE, Sequeira OR, Miño LM, Candia JC, Cáceres C, Lovera OA, Martínez JE. The relation between QRS complex fragmentation and segmental abnormalities of the myocardial contractility in patients with coronary artery disease. Indian Heart J 2021;73:325-30. [PMID: 34154750 DOI: 10.1016/j.ihj.2021.03.010] [Reference Citation Analysis]
19 Swindle J, Burroughs TE, Schnitzler MA, Hauptman PJ. Short-term mortality and cost associated with cardiac device implantation in patients hospitalized with heart failure. Am Heart J 2008;156:322-8. [PMID: 18657663 DOI: 10.1016/j.ahj.2008.04.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
20 Koplan BA, Stevenson WG. Ventricular tachycardia and sudden cardiac death. Mayo Clin Proc 2009;84:289-97. [PMID: 19252119 DOI: 10.1016/S0025-6196(11)61149-X] [Cited by in F6Publishing: 22] [Reference Citation Analysis]
21 Yap YG, Duong T, Bland JM, Malik M, Torp-Pedersen C, Køber L, Gallagher MM, Camm AJ. Optimising the dichotomy limit for left ventricular ejection fraction in selecting patients for defibrillator therapy after myocardial infarction. Heart 2007;93:832-6. [PMID: 17237132 DOI: 10.1136/hrt.2006.102186] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
22 Weber C, Neacsu I, Krautz B, Schlegel P, Sauer S, Raake P, Ritterhoff J, Jungmann A, Remppis AB, Stangassinger M, Koch WJ, Katus HA, Müller OJ, Most P, Pleger ST. Therapeutic safety of high myocardial expression levels of the molecular inotrope S100A1 in a preclinical heart failure model. Gene Ther 2014;21:131-8. [PMID: 24305416 DOI: 10.1038/gt.2013.63] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
23 Kim HW, Klem I, Shah DJ, Wu E, Meyers SN, Parker MA, Crowley AL, Bonow RO, Judd RM, Kim RJ. Unrecognized non-Q-wave myocardial infarction: prevalence and prognostic significance in patients with suspected coronary disease. PLoS Med 2009;6:e1000057. [PMID: 19381280 DOI: 10.1371/journal.pmed.1000057] [Cited by in Crossref: 87] [Cited by in F6Publishing: 61] [Article Influence: 7.3] [Reference Citation Analysis]
24 Russo AM, Daugherty SL, Masoudi FA, Wang Y, Curtis J, Lampert R. Gender and outcomes after primary prevention implantable cardioverter-defibrillator implantation: Findings from the National Cardiovascular Data Registry (NCDR). Am Heart J 2015;170:330-8. [PMID: 26299231 DOI: 10.1016/j.ahj.2015.02.025] [Cited by in Crossref: 45] [Cited by in F6Publishing: 28] [Article Influence: 7.5] [Reference Citation Analysis]
25 Friedman DJ, Parzynski CS, Varosy PD, Prutkin JM, Patton KK, Mithani A, Russo AM, Curtis JP, Al-Khatib SM. Trends and In-Hospital Outcomes Associated With Adoption of the Subcutaneous Implantable Cardioverter Defibrillator in the United States. JAMA Cardiol 2016;1:900-11. [PMID: 27603935 DOI: 10.1001/jamacardio.2016.2782] [Cited by in Crossref: 80] [Cited by in F6Publishing: 60] [Article Influence: 26.7] [Reference Citation Analysis]
26 Gula LJ, Klein GJ, Hellkamp AS, Massel D, Krahn AD, Skanes AC, Yee R, Anderson J, Johnson GW, Poole JE, Mark DB, Lee KL, Bardy GH. Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J 2008;156:1196-200. [PMID: 19033019 DOI: 10.1016/j.ahj.2008.08.007] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
27 Gula LJ, Krahn AD, Skanes AC, Yee R, Klein GJ. Clinical relevance of arrhythmias during sleep: guidance for clinicians. Heart 2004;90:347-52. [PMID: 14966068 DOI: 10.1136/hrt.2003.019323] [Cited by in Crossref: 39] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
28 Connelly DT. Implantable cardioverter-defibrillators. Heart 2001;86:221-6. [PMID: 11454851 DOI: 10.1136/heart.86.2.221] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
29 Exner D. Noninvasive risk stratification after myocardial infarction: rationale, current evidence and the need for definitive trials. Can J Cardiol 2009;25 Suppl A:21A-7A. [PMID: 19521570 DOI: 10.1016/s0828-282x(09)71050-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
30 Lee BK, Olgin JE. Role of wearable and automatic external defibrillators in improving survival in patients at risk for sudden cardiac death. Curr Treat Options Cardiovasc Med 2009;11:360-5. [PMID: 19846033 DOI: 10.1007/s11936-009-0036-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
31 Keller SP, Halperin HR. Cardiac arrest: the changing incidence of ventricular fibrillation. Curr Treat Options Cardiovasc Med 2015;17:392. [PMID: 25981196 DOI: 10.1007/s11936-015-0392-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
32 Janardhan AH, Li W, Fedorov VV, Yeung M, Wallendorf MJ, Schuessler RB, Efimov IR. A novel low-energy electrotherapy that terminates ventricular tachycardia with lower energy than a biphasic shock when antitachycardia pacing fails. J Am Coll Cardiol 2012;60:2393-8. [PMID: 23141483 DOI: 10.1016/j.jacc.2012.08.1001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
33 England R, England T, Coggon J. The ethical and legal implications of deactivating an implantable cardioverter-defibrillator in a patient with terminal cancer. J Med Ethics 2007;33:538-40. [PMID: 17761824 DOI: 10.1136/jme.2006.017657] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
34 Lercher P, Rotman B, Scherr D, Kraxner W, Luha O, Klein W. [The impact of the Multicenter Automatic Defibrillator Implantation Trial II in a university hospital--do all patients with myocardial infarction and reduced left ventricular function need an implantable cardioverter-defibrillator?]. Wien Klin Wochenschr 2003;115:167-74. [PMID: 12741076 DOI: 10.1007/BF03040304] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
35 Jolley M, Stinstra J, Pieper S, Macleod R, Brooks DH, Cecchin F, Triedman JK. A computer modeling tool for comparing novel ICD electrode orientations in children and adults. Heart Rhythm 2008;5:565-72. [PMID: 18362024 DOI: 10.1016/j.hrthm.2008.01.018] [Cited by in Crossref: 52] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
36 Mijic D, Lemke B, Bogossian H. [Fitness to drive in patients with cardiovascular implantable electronic devices]. Herzschrittmacherther Elektrophysiol 2019;30:150-5. [PMID: 31073643 DOI: 10.1007/s00399-019-0626-y] [Reference Citation Analysis]
37 Tereshchenko LG, Faddis MN, Fetics BJ, Zelik KE, Efimov IR, Berger RD. Transient local injury current in right ventricular electrogram after implantable cardioverter-defibrillator shock predicts heart failure progression. J Am Coll Cardiol 2009;54:822-8. [PMID: 19695461 DOI: 10.1016/j.jacc.2009.06.004] [Cited by in Crossref: 51] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
38 Simon T, Becker R, Voss F, Bikou O, Hauck M, Licka M, Katus HA, Bauer A. Elevated B-type natriuretic peptide levels in patients with nonischemic cardiomyopathy predict occurrence of arrhythmic events. Clin Res Cardiol 2008;97:306-9. [PMID: 18193374 DOI: 10.1007/s00392-007-0629-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
39 Shun-Shin MJ, Zheng SL, Cole GD, Howard JP, Whinnett ZI, Francis DP. Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials. Eur Heart J 2017;38:1738-46. [PMID: 28329280 DOI: 10.1093/eurheartj/ehx028] [Cited by in Crossref: 59] [Cited by in F6Publishing: 31] [Article Influence: 19.7] [Reference Citation Analysis]
40 Fong MW, Grazette L, Cesario D, Cao M, Saxon L. Treatment of ventricular tachycardia in patients with heart failure. Curr Cardiol Rep 2011;13:203-9. [PMID: 21445560 DOI: 10.1007/s11886-011-0182-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
41 Gatzoulis KA, Karystinos G, Gialernios T, Sotiropoulos H, Synetos A, Dilaveris P, Sideris S, Kalikazaros I, Olshansky B, Stefanadis CI. Correlation of noninvasive electrocardiography with invasive electrophysiology in syncope of unknown origin: implications from a large syncope database. Ann Noninvasive Electrocardiol 2009;14:119-27. [PMID: 19419396 DOI: 10.1111/j.1542-474X.2009.00286.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
42 Providência R, Kramer DB, Pimenta D, Babu GG, Hatfield LA, Ioannou A, Novak J, Hauser RG, Lambiase PD. Transvenous Implantable Cardioverter-Defibrillator (ICD) Lead Performance: A Meta-Analysis of Observational Studies. J Am Heart Assoc 2015;4:e002418. [PMID: 26518666 DOI: 10.1161/JAHA.115.002418] [Cited by in Crossref: 37] [Cited by in F6Publishing: 2] [Article Influence: 6.2] [Reference Citation Analysis]
43 Friedman DJ, Al-Khatib SM, Zeitler EP, Han J, Bardy GH, Poole JE, Bigger JT, Buxton AE, Moss AJ, Lee KL, Steinman R, Dorian P, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Inoue LYT, Sanders GD. New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trials. Am Heart J 2017;191:21-9. [PMID: 28888266 DOI: 10.1016/j.ahj.2017.06.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
44 Furushima H, Chinushi M, Sugiura H, Kasai H, Washizuka T, Aizawa Y. Ventricular tachyarrhythmia associated with cardiac sarcoidosis: its mechanisms and outcome. Clin Cardiol 2004;27:217-22. [PMID: 15119697 DOI: 10.1002/clc.4960270409] [Cited by in Crossref: 95] [Cited by in F6Publishing: 60] [Article Influence: 5.6] [Reference Citation Analysis]
45 Nakata T, Hashimoto A, Sugawara H. Cardiac metaiodobenzylguanidine imaging and heart failure. Curr Heart Fail Rep 2013;10:359-64. [PMID: 24091807 DOI: 10.1007/s11897-013-0161-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
46 Song X, Liu Y, Hu Y, Zhao X, Tian J, Ding G, Wang S. Short-Term Exposure to Air Pollution and Cardiac Arrhythmia: A Meta-Analysis and Systematic Review. Int J Environ Res Public Health 2016;13:E642. [PMID: 27367707 DOI: 10.3390/ijerph13070642] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 6.6] [Reference Citation Analysis]
47 Zhang Y, Guallar E, Blasco-Colmenares E, Butcher B, Norgard S, Nauffal V, Marine JE, Eldadah Z, Dickfeld T, Ellenbogen KA, Tomaselli GF, Cheng A. Changes in Follow-Up Left Ventricular Ejection Fraction Associated With Outcomes in Primary Prevention Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Recipients. J Am Coll Cardiol 2015;66:524-31. [PMID: 26227190 DOI: 10.1016/j.jacc.2015.05.057] [Cited by in Crossref: 60] [Cited by in F6Publishing: 33] [Article Influence: 10.0] [Reference Citation Analysis]
48 Gandhi K, Aronow WS, Desai H, Amin H, Lai HM, Frishman WH, Cohen M, Sorbera C. Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up. Arch Med Sci 2010;6:900-3. [PMID: 22427764 DOI: 10.5114/aoms.2010.19299] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
49 Pezawas T, Diedrich A, Robertson D, Winker R, Richter B, Wang L, Schmidinger H. Risk of arrhythmic death in ischemic heart disease: a prospective, controlled, observer-blind risk stratification over 10 years. Eur J Clin Invest 2017;47:231-40. [PMID: 28102901 DOI: 10.1111/eci.12729] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
50 Lujan HL, DiCarlo SE. Partial hindlimb occlusion reduced the susceptibility to sustained ventricular tachycardia in conscious rats. J Cardiovasc Pharmacol Ther 2009;14:199-206. [PMID: 19721132 DOI: 10.1177/1074248409340160] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
51 Pruvot EJ, Rosenbaum DS. T-wave alternans for risk stratification and prevention of sudden cardiac death. Curr Cardiol Rep 2003;5:350-7. [PMID: 12917048 DOI: 10.1007/s11886-003-0090-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
52 Fishman GI, Chugh SS, Dimarco JP, Albert CM, Anderson ME, Bonow RO, Buxton AE, Chen PS, Estes M, Jouven X. Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Circulation. 2010;122:2335-2348. [PMID: 21147730 DOI: 10.1161/circulationaha.110.976092] [Cited by in Crossref: 390] [Cited by in F6Publishing: 160] [Article Influence: 39.0] [Reference Citation Analysis]
53 Sciammarella MG, Gerson M, Buxton AE, Bartley SC, Doukky R, Merlino DA, Tandon S, Thompson R, Travin MI. ASNC/SNMMI Model Coverage Policy: Myocardial sympathetic innervation imaging: Iodine-123 meta-iodobenzylguanidine ((123)I-mIBG). J Nucl Cardiol 2015;22:804-11. [PMID: 26163203 DOI: 10.1007/s12350-015-0202-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
54 Gold MR, Lambiase PD, El-Chami MF, Knops RE, Aasbo JD, Bongiorni MG, Russo AM, Deharo JC, Burke MC, Dinerman J, Barr CS, Shaik N, Carter N, Stoltz T, Stein KM, Brisben AJ, Boersma LVA; UNTOUCHED Investigators*. Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial. Circulation 2021;143:7-17. [PMID: 33073614 DOI: 10.1161/CIRCULATIONAHA.120.048728] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 14.0] [Reference Citation Analysis]
55 Rosman J, Hanon S, Shapiro M, Evans SJ, Schweitzer P. Triggers of sustained monomorphic ventricular tachycardia differ among patients with varying etiologies of left ventricular dysfunction. Ann Noninvasive Electrocardiol 2006;11:113-7. [PMID: 16630084 DOI: 10.1111/j.1542-474X.2006.00091.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
56 Parkes J, Bryant J, Milne R. Implantable cardioverter-defibrillators in arrhythmias: a rapid and systematic review of effectiveness. Heart 2002;87:438-42. [PMID: 11997415 DOI: 10.1136/heart.87.5.438] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
57 Morgan JM. The MADIT II and COMPANION studies: will they affect uptake of device treatment? Heart 2004;90:243-5. [PMID: 14966031 DOI: 10.1136/hrt.2002.007807] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
58 Iacobas DA, Iacobas S, Thomas N, Spray DC. Sex-dependent gene regulatory networks of the heart rhythm. Funct Integr Genomics. 2010;10:73-86. [PMID: 19756788 DOI: 10.1007/s10142-009-0137-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
59 Dorenkamp M, Morguet AJ, Sticherling C, Behrens S, Zabel M. Long-term prognostic value of restitution slope in patients with ischemic and dilated cardiomyopathies. PLoS One 2013;8:e54768. [PMID: 23349967 DOI: 10.1371/journal.pone.0054768] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
60 Wilkoff BL. Should all patients receive dual chamber pacing ICDs? The rationale for the DAVID trial. Curr Control Trials Cardiovasc Med 2001;2:215-7. [PMID: 11806799 DOI: 10.1186/cvm-2-5-215] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
61 Stutts LA, Cross NJ, Conti JB, Sears SF. Examination of research trends on patient factors in patients with implantable cardioverter defibrillators. Clin Cardiol 2007;30:64-8. [PMID: 17326060 DOI: 10.1002/clc.20035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
62 Khan HM, Leslie SJ. Risk factors for sudden cardiac death to determine high risk patients in specific patient populations that may benefit from a wearable defibrillator. World J Cardiol 2019;11:103-19. [PMID: 31040933 DOI: 10.4330/wjc.v11.i3.103] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Zhang Y, Kennedy R, Blasco-Colmenares E, Butcher B, Norgard S, Eldadah Z, Dickfeld T, Ellenbogen KA, Marine JE, Guallar E, Tomaselli GF, Cheng A. Outcomes in African Americans undergoing cardioverter-defibrillator implantation for primary prevention of sudden cardiac death: findings from the Prospective Observational Study of Implantable Cardioverter-Defibrillators (PROSE-ICD). Heart Rhythm 2014;11:1377-83. [PMID: 24793459 DOI: 10.1016/j.hrthm.2014.04.039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
64 McComb JM, Camm AJ. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators. BMJ 2002;325:1050-1. [PMID: 12424150 DOI: 10.1136/bmj.325.7372.1050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
65 Srinivasan NT, Schilling RJ. Sudden Cardiac Death and Arrhythmias. Arrhythm Electrophysiol Rev 2018;7:111-7. [PMID: 29967683 DOI: 10.15420/aer.2018:15:2] [Cited by in Crossref: 50] [Cited by in F6Publishing: 18] [Article Influence: 16.7] [Reference Citation Analysis]
66 Gold MR, Ip JH, Costantini O, Poole JE, McNulty S, Mark DB, Lee KL, Bardy GH. Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy. Circulation. 2008;118:2022-2028. [PMID: 18955671 DOI: 10.1161/circulationaha.107.748962] [Cited by in Crossref: 135] [Cited by in F6Publishing: 37] [Article Influence: 10.4] [Reference Citation Analysis]
67 Gloschat CR, Koppel AC, Aras KK, Brennan JA, Holzem KM, Efimov IR. Arrhythmogenic and metabolic remodelling of failing human heart. J Physiol 2016;594:3963-80. [PMID: 27019074 DOI: 10.1113/JP271992] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
68 Santini M, Lavalle C, Ricci RP. Primary and secondary prevention of sudden cardiac death: who should get an ICD? Heart 2007;93:1478-83. [PMID: 17934011 DOI: 10.1136/hrt.2006.095190] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
69 Hayashi M, Shimizu W, Albert CM. The spectrum of epidemiology underlying sudden cardiac death. Circ Res. 2015;116:1887-1906. [PMID: 26044246 DOI: 10.1161/circresaha.116.304521] [Cited by in Crossref: 260] [Cited by in F6Publishing: 99] [Article Influence: 43.3] [Reference Citation Analysis]
70 Banasik G, Segiet O, Elwart M, Szulik M, Lenarczyk R, Kalarus Z, Kukulski T. LV mechanical dispersion as a predictor of ventricular arrhythmia in patients with advanced systolic heart failure : A pilot study. Herz 2016;41:599-604. [PMID: 26883898 DOI: 10.1007/s00059-015-4398-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
71 Khazanie P, Hellkamp AS, Fonarow GC, Bhatt DL, Masoudi FA, Anstrom KJ, Heidenreich PA, Yancy CW, Curtis LH, Hernandez AF, Peterson ED, Al-Khatib SM. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention. J Am Heart Assoc 2015;4:e002061. [PMID: 26251283 DOI: 10.1161/JAHA.115.002061] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
72 Chan LL, Lim CP, Aung ST, Quetua P, Ho KL, Chong D, Teo WS, Sim D, Ching CK. Patient barriers to implantable cardioverter defibrillator implantation for the primary prevention of sudden cardiac death in patients with heart failure and reduced ejection fraction. Singapore Med J 2016;57:182-7. [PMID: 27075476 DOI: 10.11622/smedj.2016072] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
73 Fukuda T, Ohashi-Fukuda N, Kondo Y, Sera T, Doi K, Yahagi N. Epidemiology, Risk Factors, and Outcomes of Out-of-Hospital Cardiac Arrest Caused by Stroke: A Population-Based Study. Medicine (Baltimore) 2016;95:e3107. [PMID: 27057834 DOI: 10.1097/MD.0000000000003107] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 2.4] [Reference Citation Analysis]
74 Batchvarov VN, Hnatkova K, Poloniecki J, Camm AJ, Malik M. Prognostic value of heterogeneity of ventricular repolarization in survivors of acute myocardial infarction. Clin Cardiol 2004;27:653-9. [PMID: 15562938 DOI: 10.1002/clc.4960271115] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
75 Fisher JD, Buxton AE, Lee KL, Packer DL, Echt DS, Denes P, Lehmann MH, DiMarco JP, Roy D, Hafley GE; MUSTT Events Committee. Designation and distribution of events in the Multicenter UnSustained Tachycardia Trial (MUSTT). Am J Cardiol 2007;100:76-83. [PMID: 17599445 DOI: 10.1016/j.amjcard.2007.02.055] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
76 Reeder HT, Shen C, Buxton AE, Haneuse SJ, Kramer DB. Joint Shock/Death Risk Prediction Model for Patients Considering Implantable Cardioverter-Defibrillators. Circ Cardiovasc Qual Outcomes 2019;12:e005675. [PMID: 31412732 DOI: 10.1161/CIRCOUTCOMES.119.005675] [Cited by in Crossref: 7] [Article Influence: 3.5] [Reference Citation Analysis]
77 Yamazaki M, Honjo H, Ashihara T, Harada M, Sakuma I, Nakazawa K, Trayanova N, Horie M, Kalifa J, Jalife J, Kamiya K, Kodama I. Regional cooling facilitates termination of spiral-wave reentry through unpinning of rotors in rabbit hearts. Heart Rhythm 2012;9:107-14. [PMID: 21839044 DOI: 10.1016/j.hrthm.2011.08.013] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
78 Undavia M, Goldstein NE, Cohen P, Sinthawanarong K, Singson M, Bhutani D, Munson T, Gomes JA, Fischer A, Mehta D. Impact of implantable cardioverter-defibrillator recalls on patients' anxiety, depression, and quality of life. Pacing Clin Electrophysiol 2008;31:1411-8. [PMID: 18950298 DOI: 10.1111/j.1540-8159.2008.01204.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
79 Makimoto H, Zielke S, Clasen L, Lin T, Gerguri S, Müller P, Schmidt J, Bejinariu A, Kurt M, Brinkmeyer C, Stern M, Kelm M, Fürnkranz A. Clinical significance of precedent asymptomatic non-sustained ventricular tachycardias on subsequent ICD interventions and heart failure hospitalization in primary prevention ICD patients. Eur J Med Res 2020;25:5. [PMID: 32183891 DOI: 10.1186/s40001-020-0401-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Al-Khatib SM, Sanders GD, O'Brien SM, Matlock D, Zimmer LO, Masoudi FA, Peterson E. Do physicians' attitudes toward implantable cardioverter defibrillator therapy vary by patient age, gender, or race? Ann Noninvasive Electrocardiol 2011;16:77-84. [PMID: 21251138 DOI: 10.1111/j.1542-474X.2010.00412.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
81 Darouian N, Narayanan K, Aro AL, Reinier K, Uy-Evanado A, Teodorescu C, Gunson K, Jui J, Chugh SS. Delayed intrinsicoid deflection of the QRS complex is associated with sudden cardiac arrest. Heart Rhythm 2016;13:927-32. [PMID: 26699237 DOI: 10.1016/j.hrthm.2015.12.022] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
82 Goldstein NE, Mehta D, Siddiqui S, Teitelbaum E, Zeidman J, Singson M, Pe E, Bradley EH, Morrison RS. "That's like an act of suicide" patients' attitudes toward deactivation of implantable defibrillators. J Gen Intern Med 2008;23 Suppl 1:7-12. [PMID: 18095037 DOI: 10.1007/s11606-007-0239-8] [Cited by in Crossref: 113] [Cited by in F6Publishing: 64] [Article Influence: 8.7] [Reference Citation Analysis]
83 Barakat AF, Mahmoud AN, Elgendy IY. Primary prevention implantable cardioverter defibrillator in patients with reduced ejection fraction: for ischemic or non-ischemic cardiomyopathy or both? J Thorac Dis 2017;9:2749-51. [PMID: 29221231 DOI: 10.21037/jtd.2017.08.97] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
84 Hess PL, Laird A, Edwards R, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Hall WJ, Steinman R, Dorian P, Hallstrom A, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Al-Khatib SM, Piccini JP, Inoue LY, Sanders GD. Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials. Heart Rhythm 2013;10:828-35. [PMID: 23416381 DOI: 10.1016/j.hrthm.2013.02.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
85 Ricci RP, D'Onofrio A, Padeletti L, Sagone A, Vicentini A, Vincenti A, Morichelli L, Cavallaro C, Ricciardi G, Lombardi L, Fusco A, Rovaris G, Silvestri P, Guidotto T, Pollastrelli A, Santini M. Rationale and design of the health economics evaluation registry for remote follow-up: TARIFF. Europace 2012;14:1661-5. [PMID: 22544910 DOI: 10.1093/europace/eus093] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
86 Adduci C, Palano F, Francia P. Safety, Efficacy and Evidence Base for Use of the Subcutaneous Implantable Cardioverter Defibrillator. J Clin Med 2018;7:E53. [PMID: 29534478 DOI: 10.3390/jcm7030053] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
87 Darbar D. Genomics, heart failure and sudden cardiac death. Heart Fail Rev. 2010;15:229-238. [PMID: 18437561 DOI: 10.1007/s10741-008-9095-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
88 Link MS, Exner DV, Anderson M, Ackerman M, Al-Ahmad A, Knight BP, Markowitz SM, Kaufman ES, Haines D, Asirvatham SJ, Callans DJ, Mounsey JP, Bogun F, Narayan SM, Krahn AD, Mittal S, Singh J, Fisher JD, Chugh SS. HRS policy statement: clinical cardiac electrophysiology fellowship curriculum: update 2011. Heart Rhythm 2011;8:1340-56. [PMID: 21699868 DOI: 10.1016/j.hrthm.2011.06.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
89 Al-Khatib SM, Friedman DJ, Sanders GD. When Is It Safe Not to Reimplant an Implantable Cardioverter Defibrillator at the Time of Battery Depletion? Card Electrophysiol Clin 2018;10:137-44. [PMID: 29428135 DOI: 10.1016/j.ccep.2017.11.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
90 Kennedy HL. The history, science, and innovation of Holter technology. Ann Noninvasive Electrocardiol 2006;11:85-94. [PMID: 16472287 DOI: 10.1111/j.1542-474X.2006.00067.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
91 Ishikawa K, Ladage D, Takewa Y, Yaniz E, Chen J, Tilemann L, Sakata S, Badimon JJ, Hajjar RJ, Kawase Y. Development of a preclinical model of ischemic cardiomyopathy in swine. Am J Physiol Heart Circ Physiol 2011;301:H530-7. [PMID: 21551276 DOI: 10.1152/ajpheart.01103.2010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
92 Al-Khatib SM, Hellkamp AS, Hernandez AF, Fonarow GC, Thomas KL, Al-Khalidi HR, Heidenreich PA, Hammill S, Yancy C, Peterson ED; Get With the Guidelines Steering Committee and Hospitals. Trends in use of implantable cardioverter-defibrillator therapy among patients hospitalized for heart failure: have the previously observed sex and racial disparities changed over time? Circulation 2012;125:1094-101. [PMID: 22287589 DOI: 10.1161/CIRCULATIONAHA.111.066605] [Cited by in Crossref: 85] [Cited by in F6Publishing: 41] [Article Influence: 9.4] [Reference Citation Analysis]
93 Fleg JL, Forman DE, Berra K, Bittner V, Blumenthal JA, Chen MA, Cheng S, Kitzman DW, Maurer MS, Rich MW, Shen WK, Williams MA, Zieman SJ; American Heart Association Committees on Older Populations and Exercise Cardiac Rehabilitation and Prevention of the Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Council on Lifestyle and Cardiometabolic He. Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association. Circulation 2013;128:2422-46. [PMID: 24166575 DOI: 10.1161/01.cir.0000436752.99896.22] [Cited by in Crossref: 120] [Cited by in F6Publishing: 78] [Article Influence: 15.0] [Reference Citation Analysis]
94 Lujan HL, Palani G, Zhang L, DiCarlo SE. Targeted ablation of cardiac sympathetic neurons reduces the susceptibility to ischemia-induced sustained ventricular tachycardia in conscious rats. Am J Physiol Heart Circ Physiol 2010;298:H1330-9. [PMID: 20173045 DOI: 10.1152/ajpheart.00955.2009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
95 Kreuz J, Horlbeck F, Schrickel J, Linhart M, Fimmers R, Mellert F, Nickenig G, Schwab JO. Kidney dysfunction and deterioration of ejection fraction pose independent risk factors for mortality in implantable cardioverter-defibrillator recipients for primary prevention. Clin Cardiol 2012;35:575-9. [PMID: 22707222 DOI: 10.1002/clc.22018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
96 Papadimitriou L, Moore CK, Butler J, Long RC. The Limitations of Symptom-based Heart Failure Management. Card Fail Rev 2019;5:74-7. [PMID: 31179015 DOI: 10.15420/cfr.2019.3.2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
97 McElwee SK, Velasco A, Doppalapudi H. Mechanisms of sudden cardiac death. J Nucl Cardiol. 2016;23:1368-1379. [PMID: 27457531 DOI: 10.1007/s12350-016-0600-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 3.2] [Reference Citation Analysis]
98 Al-Khatib SM, Hellkamp AS, Fonarow GC, Mark DB, Curtis LH, Hernandez AF, Anstrom KJ, Peterson ED, Sanders GD, Al-Khalidi HR, Hammill BG, Heidenreich PA, Hammill SC. Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%. JAMA. 2014;311:2209-2215. [PMID: 24893088 DOI: 10.1001/jama.2014.5310] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
99 Arawwawala D, Brett SJ. Clinical review: beyond immediate survival from resuscitation-long-term outcome considerations after cardiac arrest. Crit Care 2007;11:235. [PMID: 18177512 DOI: 10.1186/cc6139] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
100 Ripplinger CM, Lou Q, Li W, Hadley J, Efimov IR. Panoramic imaging reveals basic mechanisms of induction and termination of ventricular tachycardia in rabbit heart with chronic infarction: implications for low-voltage cardioversion. Heart Rhythm 2009;6:87-97. [PMID: 18996057 DOI: 10.1016/j.hrthm.2008.09.019] [Cited by in Crossref: 50] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
101 Kramer DB, Matlock DD, Buxton AE, Goldstein NE, Goodwin C, Green AR, Kirkpatrick JN, Knoepke C, Lampert R, Mueller PS, Reynolds MR, Spertus JA, Stevenson LW, Mitchell SL. Implantable Cardioverter-Defibrillator Use in Older Adults: Proceedings of a Hartford Change AGEnts Symposium. Circ Cardiovasc Qual Outcomes 2015;8:437-46. [PMID: 26038525 DOI: 10.1161/CIRCOUTCOMES.114.001660] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
102 Castellanos JM, Smith LM, Varosy PD, Dehlendorf C, Marcus GM. Referring physicians' discordance with the primary prevention implantable cardioverter-defibrillator guidelines: a national survey. Heart Rhythm 2012;9:874-81. [PMID: 22306794 DOI: 10.1016/j.hrthm.2012.01.029] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
103 Teodorescu C, Reinier K, Uy-Evanado A, Gunson K, Jui J, Chugh SS. Resting heart rate and risk of sudden cardiac death in the general population: influence of left ventricular systolic dysfunction and heart rate-modulating drugs. Heart Rhythm 2013;10:1153-8. [PMID: 23680897 DOI: 10.1016/j.hrthm.2013.05.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
104 Ziv O, Schofield L, Lau E, Chaves L, Patel D, Jeng P, Peng X, Choi BR, Koren G. A novel, minimally invasive, segmental myocardial infarction with a clear healed infarct borderzone in rabbits. Am J Physiol Heart Circ Physiol 2012;302:H2321-30. [PMID: 22447944 DOI: 10.1152/ajpheart.00031.2012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
105 Feingold B, Arora G, Webber SA, Smith KJ. Cost-effectiveness of implantable cardioverter-defibrillators in children with dilated cardiomyopathy. J Card Fail 2010;16:734-41. [PMID: 20797597 DOI: 10.1016/j.cardfail.2010.04.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
106 Tsukahara K, Oginosawa Y, Fujino Y, Honda T, Kikuchi K, Nozoe M, Uchida T, Minamiguchi H, Sonoda K, Ogawa M, Ideguchi T, Kizaki Y, Nakamura T, Oba K, Higa S, Yoshida K, Yagyu K, Miyamoto T, Yamagishi Y, Ohe H, Kohno R, Kataoka M, Otsuji Y, Abe H. RR interval variability in the evaluation of ventricular tachycardia and effects of implantable cardioverter defibrillator therapy. J Arrhythm 2021;37:1052-60. [PMID: 34386132 DOI: 10.1002/joa3.12551] [Reference Citation Analysis]
107 Barsheshet A, Brenyo A, Goldenberg I, Moss AJ. Sex-related differences in patients' responses to heart failure therapy. Nat Rev Cardiol 2012;9:234-42. [PMID: 22330611 DOI: 10.1038/nrcardio.2012.10] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
108 Jolley M, Stinstra J, Tate J, Pieper S, Macleod R, Chu L, Wang P, Triedman JK. Finite element modeling of subcutaneous implantable defibrillator electrodes in an adult torso. Heart Rhythm 2010;7:692-8. [PMID: 20230927 DOI: 10.1016/j.hrthm.2010.01.030] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
109 Friedman DJ, Fudim M, Overton R, Shaw LK, Patel D, Pokorney SD, Velazquez EJ, Al-Khatib SM. The relationship between baseline and follow-up left ventricular ejection fraction with adverse events among primary prevention ICD patients. Am Heart J 2018;201:17-24. [PMID: 29910051 DOI: 10.1016/j.ahj.2018.03.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
110 Callum K, Graune C, Bowman E, Molden E, Leslie SJ. Remote monitoring of implantable defibrillators is associated with fewer inappropriate shocks and reduced time to medical assessment in a remote and rural area. World J Cardiol 2021;13:46-54. [PMID: 33791078 DOI: 10.4330/wjc.v13.i3.46] [Reference Citation Analysis]
111 Cleland JG, Chattopadhyay S, Khand A, Houghton T, Kaye GC. Prevalence and incidence of arrhythmias and sudden death in heart failure. Heart Fail Rev 2002;7:229-42. [PMID: 12215728 DOI: 10.1023/a:1020024122726] [Cited by in Crossref: 52] [Cited by in F6Publishing: 13] [Article Influence: 2.9] [Reference Citation Analysis]
112 Kusumoto F, Goldschlager N. Implantable cardiac arrhythmia devices--Part II: implantable cardioverter defibrillators and implantable loop recorders. Clin Cardiol 2006;29:237-42. [PMID: 16796072 DOI: 10.1002/clc.4960290603] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
113 Zhang Y, Guallar E, Blasco-Colmenares E, Dalal D, Butcher B, Norgard S, Tjong FV, Eldadah Z, Dickfeld T, Ellenbogen KA, Marine JE, Tomaselli GF, Cheng A. Clinical and serum-based markers are associated with death within 1 year of de novo implant in primary prevention ICD recipients. Heart Rhythm 2015;12:360-6. [PMID: 25446153 DOI: 10.1016/j.hrthm.2014.10.034] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
114 Rohde LE, Bertoldi EG, Goldraich L, Polanczyk CA. Cost-effectiveness of heart failure therapies. Nat Rev Cardiol 2013;10:338-54. [PMID: 23609174 DOI: 10.1038/nrcardio.2013.60] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 5.4] [Reference Citation Analysis]
115 Sodhi SS, Cedars AM. Primary Prevention of Sudden Cardiac Death in Adults with Transposition of the Great Arteries: A Review of Implantable Cardioverter-Defibrillator Placement. Tex Heart Inst J 2015;42:309-18. [PMID: 26413012 DOI: 10.14503/THIJ-14-4352] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
116 Olgin JE, Pletcher MJ, Vittinghoff E, Wranicz J, Malik R, Morin DP, Zweibel S, Buxton AE, Elayi CS, Chung EH, Rashba E, Borggrefe M, Hue TF, Maguire C, Lin F, Simon JA, Hulley S, Lee BK; VEST Investigators. Wearable Cardioverter-Defibrillator after Myocardial Infarction. N Engl J Med. 2018;379:1205-1215. [PMID: 30280654 DOI: 10.1056/nejmoa1800781] [Cited by in Crossref: 106] [Cited by in F6Publishing: 21] [Article Influence: 35.3] [Reference Citation Analysis]
117 Briongos-Figuero S, Estévez A, Pérez ML, Martínez-Ferrer JB, García E, Viñolas X, Arenal Á, Alzueta J, Muñoz-Aguilera R. Prognostic role of NYHA class in heart failure patients undergoing primary prevention ICD therapy. ESC Heart Fail 2020;7:279-83. [PMID: 31823514 DOI: 10.1002/ehf2.12548] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
118 Nisam S, Henry S, Wilber DJ. Implementation of MADIT and MUSTT in clinical practice: results of an international survey. Ann Noninvasive Electrocardiol 2002;7:399-405. [PMID: 12431320 DOI: 10.1111/j.1542-474x.2002.tb00191.x] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
119 Piccini JP, Al-Khatib SM, Hellkamp AS, Anstrom KJ, Poole JE, Mark DB, Lee KL, Bardy GH. Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Heart Rhythm 2011;8:393-400. [PMID: 21109025 DOI: 10.1016/j.hrthm.2010.11.033] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
120 Nazarian S, Bluemke DA, Halperin HR. Applications of cardiac magnetic resonance in electrophysiology. Circ Arrhythm Electrophysiol 2009;2:63-71. [PMID: 19808444 DOI: 10.1161/CIRCEP.108.811562] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
121 Adabag AS, Maron BJ. Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy. Ann Noninvasive Electrocardiol 2007;12:171-80. [PMID: 17593187 DOI: 10.1111/j.1542-474X.2007.00157.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
122 Santini M, Russo M, Botto G, Lunati M, Proclemer A, Schmidt B, Erdogan A, Helmling E, Rauhe W, Desaga M, Santi E, Messier M, Boriani G. Clinical and arrhythmic outcomes after implantation of a defibrillator for primary prevention of sudden death in patients with post-myocardial infarction cardiomyopathy: The Survey to Evaluate Arrhythmia Rate in High-risk MI patients (SEARCH-MI). Europace 2009;11:476-82. [PMID: 19136492 DOI: 10.1093/europace/eun349] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
123 Pokorney SD, Hellkamp AS, Yancy CW, Curtis LH, Hammill SC, Peterson ED, Masoudi FA, Bhatt DL, Al-Khalidi HR, Heidenreich PA, Anstrom KJ, Fonarow GC, Al-Khatib SM. Primary prevention implantable cardioverter-defibrillators in older racial and ethnic minority patients. Circ Arrhythm Electrophysiol 2015;8:145-51. [PMID: 25504649 DOI: 10.1161/CIRCEP.114.001878] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
124 Wang Y, Cuculich PS, Zhang J, Desouza KA, Vijayakumar R, Chen J, Faddis MN, Lindsay BD, Smith TW, Rudy Y. Noninvasive electroanatomic mapping of human ventricular arrhythmias with electrocardiographic imaging. Sci Transl Med 2011;3:98ra84. [PMID: 21885406 DOI: 10.1126/scitranslmed.3002152] [Cited by in Crossref: 112] [Cited by in F6Publishing: 63] [Article Influence: 12.4] [Reference Citation Analysis]
125 Ebinger MW, Krishnan S, Schuger CD. Mechanisms of ventricular arrhythmias in heart failure. Curr Heart Fail Rep 2005;2:111-7. [PMID: 16138946 DOI: 10.1007/s11897-005-0018-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
126 Völler H, Kamke W, Klein HU, Block M, Reibis R, Treusch S, Contzen K, Wegscheider K; PreSCD II registry investigators. Clinical practice of defibrillator implantation after myocardial infarction: impact of implant time: results from the PreSCD II registry. Europace 2011;13:499-508. [PMID: 21123220 DOI: 10.1093/europace/euq426] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
127 Proietti R, Joza J, Essebag V. Therapy for ventricular arrhythmias in structural heart disease: a multifaceted challenge. J Physiol 2016;594:2431-43. [PMID: 26621333 DOI: 10.1113/JP270534] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 2.4] [Reference Citation Analysis]
128 Barakat AF, Saad M, Elgendy AY, Mentias A, Abuzaid A, Mahmoud AN, Elgendy IY. Primary prevention implantable cardioverter defibrillator in patients with non-ischaemic cardiomyopathy: a meta-analysis of randomised controlled trials. BMJ Open 2017;7:e016352. [PMID: 28637742 DOI: 10.1136/bmjopen-2017-016352] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
129 Curtis AB. Are women worldwide under-treated with regard to cardiac resynchronization and sudden death prevention? J Interv Card Electrophysiol 2006;17:169-75. [PMID: 17333368 DOI: 10.1007/s10840-006-9068-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
130 Betensky BP, Dixit S. Sudden cardiac death in patients with nonischemic cardiomyopathy. Indian Heart J 2014;66 Suppl 1:S35-45. [PMID: 24568827 DOI: 10.1016/j.ihj.2013.12.047] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
131 Zeitler EP, Wang Y, Dharmarajan K, Anstrom KJ, Peterson ED, Daubert JP, Curtis JP, Al-Khatib SM. Outcomes 1 Year After Implantable Cardioverter-Defibrillator Lead Abandonment Versus Explantation for Unused or Malfunctioning Leads: A Report from the National Cardiovascular Data Registry. Circ Arrhythm Electrophysiol 2016;9:e003953. [PMID: 27406605 DOI: 10.1161/CIRCEP.116.003953] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 3.3] [Reference Citation Analysis]
132 Reinier K, Dervan C, Singh T, Uy-Evanado A, Lai S, Gunson K, Jui J, Chugh SS. Increased left ventricular mass and decreased left ventricular systolic function have independent pathways to ventricular arrhythmogenesis in coronary artery disease. Heart Rhythm. 2011;8:1177-1182. [PMID: 21376836 DOI: 10.1016/j.hrthm.2011.02.037] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 4.8] [Reference Citation Analysis]
133 Masoudi FA, Go AS, Magid DJ, Cassidy-Bushrow AE, Doris JM, Fiocchi F, Garcia-Montilla R, Glenn KA, Goldberg RJ, Gupta N, Gurwitz JH, Hammill SC, Hayes JJ, Jackson N, Kadish A, Lauer M, Miller AW, Multerer D, Peterson PN, Reifler LM, Reynolds K, Saczynski JS, Schuger C, Sharma PP, Smith DH, Suits M, Sung SH, Varosy PD, Vidaillet HJ, Greenlee RT. Longitudinal study of implantable cardioverter-defibrillators: methods and clinical characteristics of patients receiving implantable cardioverter-defibrillators for primary prevention in contemporary practice. Circ Cardiovasc Qual Outcomes 2012;5:e78-85. [PMID: 23170006 DOI: 10.1161/CIRCOUTCOMES.112.965368] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
134 Ng J, Jacobson JT, Ng JK, Gordon D, Lee DC, Carr JC, Goldberger JJ. Virtual electrophysiological study in a 3-dimensional cardiac magnetic resonance imaging model of porcine myocardial infarction. J Am Coll Cardiol 2012;60:423-30. [PMID: 22633654 DOI: 10.1016/j.jacc.2012.03.029] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
135 Ayesta A, Martínez-Sellés H, Bayés de Luna A, Martínez-Sellés M. Prediction of sudden death in elderly patients with heart failure. J Geriatr Cardiol 2018;15:185-92. [PMID: 29662512 DOI: 10.11909/j.issn.1671-5411.2018.02.008] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
136 Al-Khatib SM, Greiner MA, Peterson ED, Hernandez AF, Schulman KA, Curtis LH. Patient and implanting physician factors associated with mortality and complications after implantable cardioverter-defibrillator implantation, 2002-2005. Circ Arrhythm Electrophysiol 2008;1:240-9. [PMID: 19169382 DOI: 10.1161/CIRCEP.108.777888] [Cited by in Crossref: 81] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
137 Eckart RE, Gula LJ, Reynolds MR, Shry EA, Maisel WH. Mortality following defibrillator implantation in patients with renal insufficiency. J Cardiovasc Electrophysiol 2006;17:940-3. [PMID: 16948736 DOI: 10.1111/j.1540-8167.2006.00550.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
138 Wegener FT, Grönefeld GC, Duray G, Ehrlich JR, Hohnloser SH. [Pharmacological therapy for ventricular arrhythmias: evidence for current treatment strategies and perspectives for the future]. Internist (Berl) 2006;47:297-304, 306-7. [PMID: 16418866 DOI: 10.1007/s00108-005-1561-z] [Reference Citation Analysis]
139 Stecker EC, Chugh SS. Prediction of sudden cardiac death: next steps in pursuit of effective methodology. J Interv Card Electrophysiol. 2011;31:101-107. [PMID: 21384153 DOI: 10.1007/s10840-010-9535-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
140 Sim DS, Jeong MH, Choi S, Yoon NS, Yoon HJ, Moon JY, Hong YJ, Kim KH, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC. Myocardial Infarction in a Young Man due to a Hypoplastic Coronary Artery. Korean Circ J 2009;39:163-7. [PMID: 19949606 DOI: 10.4070/kcj.2009.39.4.163] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
141 Goldstein NE, Kalman J, Kutner JS, Fromme EK, Hutchinson MD, Lipman HI, Matlock DD, Swetz KM, Lampert R, Herasme O, Morrison RS. A study to improve communication between clinicians and patients with advanced heart failure: methods and challenges behind the working to improve discussions about defibrillator management trial. J Pain Symptom Manage 2014;48:1236-46. [PMID: 24768595 DOI: 10.1016/j.jpainsymman.2014.03.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 2.9] [Reference Citation Analysis]
142 Hasin T, Davarashvili I, Michowitz Y, Farkash R, Presman H, Glikson M, Rav-Acha M. Association of Guideline-Based Medical Therapy with Malignant Arrhythmias and Mortality among Heart Failure Patients Implanted with Cardioverter Defibrillator (ICD) or Cardiac Resynchronization-Defibrillator Device (CRTD). J Clin Med 2021;10:1753. [PMID: 33920719 DOI: 10.3390/jcm10081753] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
143 Steinberg BA, Al-Khatib SM, Edwards R, Han J, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Steinman R, Dorian P, Hallstrom A, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Inoue LY, Sanders GD. Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trials. JACC Heart Fail. 2014;2:623-629. [PMID: 25306452 DOI: 10.1016/j.jchf.2014.06.007] [Cited by in Crossref: 51] [Cited by in F6Publishing: 35] [Article Influence: 7.3] [Reference Citation Analysis]
144 Skoda R, Nemes A, Bárczi G, Gajdácsi J, Vágó H, Ruzsa Z, Édes IF, Szabó L, Czimbalmos C, Sydó N, Dinya E, Merkely B, Becker D. Prognosis and clinical characteristics of patients with early ventricular fibrillation in the 6-week guideline-offered time period: is it safe to wait 6 weeks with the assessment? (results from the VMAJOR-MI Registry). Quant Imaging Med Surg 2021;11:402-9. [PMID: 33392039 DOI: 10.21037/qims-20-973] [Reference Citation Analysis]
145 Steinberg JS, Varma N, Cygankiewicz I, Aziz P, Balsam P, Baranchuk A, Cantillon DJ, Dilaveris P, Dubner SJ, El-Sherif N, Krol J, Kurpesa M, La Rovere MT, Lobodzinski SS, Locati ET, Mittal S, Olshansky B, Piotrowicz E, Saxon L, Stone PH, Tereshchenko L, Turakhia MP, Turitto G, Wimmer NJ, Verrier RL, Zareba W, Piotrowicz R. 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry. Ann Noninvasive Electrocardiol 2017;22. [PMID: 28480632 DOI: 10.1111/anec.12447] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 9.7] [Reference Citation Analysis]
146 Fitchet A, Doherty PJ, Bundy C, Bell W, Fitzpatrick AP, Garratt CJ. Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial. Heart. 2003;89:155-160. [PMID: 12527665 DOI: 10.1136/heart.89.2.155] [Cited by in Crossref: 91] [Cited by in F6Publishing: 66] [Article Influence: 5.1] [Reference Citation Analysis]
147 Godemann F, Butter C, Lampe F, Linden M, Schlegl M, Schultheiss HP, Behrens S. Panic disorders and agoraphobia: side effects of treatment with an implantable cardioverter/defibrillator. Clin Cardiol 2004;27:321-6. [PMID: 15237689 DOI: 10.1002/clc.4960270604] [Cited by in Crossref: 56] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
148 Berry C, Anderson N, Kirk AJ, Dominiczak AF, McMurray JJ. Renin angiotensin system inhibition is associated with reduced free radical concentrations in arteries of patients with coronary heart disease. Heart 2001;86:217-20. [PMID: 11454847 DOI: 10.1136/heart.86.2.217] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
149 Zeitler EP, Hellkamp AS, Fonarow GC, Hammill SC, Curtis LH, Hernandez AF, Al-Khalidi HR, Curtis JP, Heidenreich PA, Anstrom KJ, Peterson ED, Mark DB, Hammill BG, Sanders GD, Al-Khatib SM. Primary prevention implantable cardioverter-defibrillators and survival in older women. JACC Heart Fail 2015;3:159-67. [PMID: 25543969 DOI: 10.1016/j.jchf.2014.09.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
150 Levy R, DellaValle A, Atav AS, ur Rehman A, Sklar AH, Stamato NJ. The relationship between glomerular filtration rate and survival in patients treated with an implantable cardioverter defibrillator. Clin Cardiol 2008;31:265-9. [PMID: 18543307 DOI: 10.1002/clc.20209] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
151 Lang CC. Regional variation in ICD implantation rates: the shocking truth? Heart 2005;91:1251-3. [PMID: 16162601 DOI: 10.1136/hrt.2004.056754] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
152 Roden DM. Antiarrhythmic drugs: from mechanisms to clinical practice. Heart 2000;84:339-46. [PMID: 10956304 DOI: 10.1136/heart.84.3.339] [Cited by in Crossref: 36] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
153 Cutler MJ, Wan X, Plummer BN, Liu H, Deschenes I, Laurita KR, Hajjar RJ, Rosenbaum DS. Targeted sarcoplasmic reticulum Ca2+ ATPase 2a gene delivery to restore electrical stability in the failing heart. Circulation 2012;126:2095-104. [PMID: 23019291 DOI: 10.1161/CIRCULATIONAHA.111.071480] [Cited by in Crossref: 72] [Cited by in F6Publishing: 38] [Article Influence: 8.0] [Reference Citation Analysis]
154 Gall NP, Kearney MT, Zaman A, O'Nunain S, Fox KA, Flapan A, Nolan J. Implementation of the NICE guidelines for the primary prevention of mortality from ventricular tachyarrhythmias: implications for UK electrophysiology centres; activity modelling from the UK-HEART study. Heart 2001;86:219-20. [PMID: 11454850 DOI: 10.1136/heart.86.2.219a] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
155 Lubitz SA, Leong-Sit P, Fine N, Kramer DB, Singh J, Ellinor PT. Effectiveness of cardiac resynchronization therapy in mild congestive heart failure: systematic review and meta-analysis of randomized trials. Eur J Heart Fail 2010;12:360-6. [PMID: 20335354 DOI: 10.1093/eurjhf/hfq029] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
156 Shimoyama M, Murata Y, Sumi KI, Hamazoe R, Komuro I. Docetaxel induced cardiotoxicity. Heart 2001;86:219. [PMID: 11454849 DOI: 10.1136/heart.86.2.219] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
157 Frankenstein L, Zugck C, Nelles M, Schellberg D, Remppis A, Katus H. Primary ICD-therapy in patients with advanced heart failure: selection strategies and future trials. Clin Res Cardiol 2008;97:594-600. [PMID: 18347765 DOI: 10.1007/s00392-008-0656-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
158 Curtis JP, Luebbert JJ, Wang Y, Rathore SS, Chen J, Heidenreich PA, Hammill SC, Lampert RI, Krumholz HM. Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. JAMA. 2009;301:1661-1670. [PMID: 19383957 DOI: 10.1001/jama.2009.547] [Cited by in Crossref: 127] [Cited by in F6Publishing: 76] [Article Influence: 10.6] [Reference Citation Analysis]
159 Al-Dadah AS, Voeller RK, Rahgozar P, Lawton JS, Moon MR, Pasque MK, Damiano RJ Jr, Moazami N. Implantable cardioverter-defibrillators improve survival after coronary artery bypass grafting in patients with severely impaired left ventricular function. J Cardiothorac Surg 2007;2:6. [PMID: 17222353 DOI: 10.1186/1749-8090-2-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
160 Zuern CS, Barthel P, Bauer A. Heart rate turbulence as risk-predictor after myocardial infarction. Front Physiol 2011;2:99. [PMID: 22180744 DOI: 10.3389/fphys.2011.00099] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
161 Narasimha D, Curtis AB. Sex Differences in Utilisation and Response to Implantable Device Therapy. Arrhythm Electrophysiol Rev 2015;4:129-35. [PMID: 26835114 DOI: 10.15420/aer.2015.04.02.129] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 2.6] [Reference Citation Analysis]
162 Packer DL, Prutkin JM, Hellkamp AS, Mitchell LB, Bernstein RC, Wood F, Boehmer JP, Carlson MD, Frantz RP, McNulty SE, Rogers JG, Anderson J, Johnson GW, Walsh MN, Poole JE, Mark DB, Lee KL, Bardy GH. Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial. Circulation 2009;120:2170-6. [PMID: 19917887 DOI: 10.1161/CIRCULATIONAHA.109.853689] [Cited by in Crossref: 171] [Cited by in F6Publishing: 42] [Article Influence: 14.3] [Reference Citation Analysis]
163 Ali H, Lupo P, Cappato R. The Entirely Subcutaneous Defibrillator - A New Generation and Future Expectations. Arrhythm Electrophysiol Rev. 2015;4:116-121. [PMID: 26835112 DOI: 10.15420/aer.2015.04.02.116] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 2.2] [Reference Citation Analysis]
164 Mehra S, Chelu MG. Implantable Cardioverter-Defibrillator Shock after Stenting Across the Device Leads. Tex Heart Inst J 2016;43:88-90. [PMID: 27047295 DOI: 10.14503/THIJ-14-4759] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
165 Hall MC, Todd DM. Modern management of arrhythmias. Postgrad Med J 2006;82:117-25. [PMID: 16461474 DOI: 10.1136/pgmj.2005.033654] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
166 Holzem KM, Efimov IR. Arrhythmogenic remodelling of activation and repolarization in the failing human heart. Europace 2012;14 Suppl 5:v50-7. [PMID: 23104915 DOI: 10.1093/europace/eus275] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
167 Rav Acha M, Soifer E, Hasin T. Cardiac Implantable Electronic Miniaturized and Micro Devices. Micromachines (Basel) 2020;11:E902. [PMID: 33003460 DOI: 10.3390/mi11100902] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
168 Thijssen J, Borleffs CJ, van Rees JB, de Bie MK, van der Velde ET, van Erven L, Bax JJ, Cannegieter SC, Schalij MJ. Driving restrictions after implantable cardioverter defibrillator implantation: an evidence-based approach. Eur Heart J 2011;32:2678-87. [PMID: 21646229 DOI: 10.1093/eurheartj/ehr161] [Cited by in Crossref: 36] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
169 Ho IC, Passeri JJ, Guy ML, Ruskin JN, Ellinor PT. Impact of the multicenter automatic defibrillator implantation trial on clinical practice. Ann Noninvasive Electrocardiol 2006;11:20-7. [PMID: 16472278 DOI: 10.1111/j.1542-474X.2006.00061.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
170 Pun PH, Al-Khatib SM, Han JY, Edwards R, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Steinman R, Dorian P, Hallstrom A, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Hess PL, Inoue LY, Sanders GD. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials. Am J Kidney Dis 2014;64:32-9. [PMID: 24518128 DOI: 10.1053/j.ajkd.2013.12.009] [Cited by in Crossref: 67] [Cited by in F6Publishing: 47] [Article Influence: 9.6] [Reference Citation Analysis]
171 Li W, Ripplinger CM, Lou Q, Efimov IR. Multiple monophasic shocks improve electrotherapy of ventricular tachycardia in a rabbit model of chronic infarction. Heart Rhythm 2009;6:1020-7. [PMID: 19560090 DOI: 10.1016/j.hrthm.2009.03.015] [Cited by in Crossref: 44] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
172 Al-Khatib SM, Mi X, Wilkoff BL, Qualls LG, Frazier-Mills C, Setoguchi S, Hess PL, Curtis LH. Follow-up of patients with new cardiovascular implantable electronic devices: are experts' recommendations implemented in routine clinical practice? Circ Arrhythm Electrophysiol 2013;6:108-16. [PMID: 23264436 DOI: 10.1161/CIRCEP.112.974337] [Cited by in Crossref: 27] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
173 Singh BN. Significance and control of cardiac arrhythmias in patients with congestive cardiac failure. Heart Fail Rev 2002;7:285-300. [PMID: 12215733 DOI: 10.1023/a:1020001912248] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
174 Naccarelli GV, Lukas MA. Carvedilol's antiarrhythmic properties: therapeutic implications in patients with left ventricular dysfunction. Clin Cardiol 2005;28:165-73. [PMID: 15869048 DOI: 10.1002/clc.4960280403] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
175 Aleong RG, Mulvahill MJ, Halder I, Carlson NE, Singh M, Bloom HL, Dudley SC, Ellinor PT, Shalaby A, Weiss R, Gutmann R, Sauer WH, Narayanan K, Chugh SS, Saba S, London B. Left Ventricular Dilatation Increases the Risk of Ventricular Arrhythmias in Patients With Reduced Systolic Function. J Am Heart Assoc 2015;4:e001566. [PMID: 26231842 DOI: 10.1161/JAHA.114.001566] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
176 Hoffmeister JM, Estes NA 3rd, Garlitski AC. Prevention of sudden cardiac death in patients with chronic kidney disease: risk and benefits of the implantable cardioverter defibrillator. J Interv Card Electrophysiol 2012;35:227-34. [PMID: 22956011 DOI: 10.1007/s10840-012-9711-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
177 Calò L, De Santo T, Nuccio F, Sciarra L, De Luca L, Stefano LM, Piroli E, Zuccaro L, Rebecchi M, de Ruvo E. Predictive value of microvolt T-wave alternans for cardiac death or ventricular tachyarrhythmic events in ischemic and nonischemic cardiomyopathy patients: a meta-analysis. Ann Noninvasive Electrocardiol. 2011;16:388-402. [PMID: 22008495 DOI: 10.1111/j.1542-474x.2011.00467.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
178 Guerra F, Brambatti M, Matassini MV, Capucci A. Current Therapeutic Options for Heart Failure in Elderly Patients. Biomed Res Int 2017;2017:1483873. [PMID: 29270425 DOI: 10.1155/2017/1483873] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
179 Burger AL, Schmidinger H, Ristl R, Pezawas T. Sex difference in inappropriate therapy and survival among 1471 implantable cardioverter-defibrillator recipients. J Cardiovasc Electrophysiol 2019;30:1620-5. [PMID: 31165550 DOI: 10.1111/jce.14003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
180 Berg DD, Wiviott SD, Braunwald E, Guo J, Im K, Kashani A, Gibson CM, Cannon CP, Morrow DA, Bhatt DL, Mega JL, O'Donoghue ML, Antman EM, Newby LK, Sabatine MS, Giugliano RP. Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials. Eur Heart J 2018;39:3810-20. [PMID: 30239711 DOI: 10.1093/eurheartj/ehy556] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
181 Meyborg M, Mura R, Tiefenbacher C, Becker R, Michaelsen J, Niroomand F. Comparative follow up of patients with implanted cardioverter-defibrillators after induction of sustained monomorphic ventricular tachycardias or ventricular fibrillation by programmed stimulation. Heart 2003;89:629-32. [PMID: 12748217 DOI: 10.1136/heart.89.6.629] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
182 Lane RE, Cowie MR, Chow AW. Prediction and prevention of sudden cardiac death in heart failure. Heart 2005;91:674-80. [PMID: 15831662 DOI: 10.1136/hrt.2003.025254] [Cited by in Crossref: 61] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
183 Chan PS, Birkmeyer JD, Krumholz HM, Spertus JA, Nallamothu BK. Racial and gender trends in the use of implantable cardioverter-defibrillators among Medicare beneficiaries between 1997 and 2003. Congest Heart Fail 2009;15:51-7. [PMID: 19379450 DOI: 10.1111/j.1751-7133.2009.00060.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
184 Berenbom LD, Weiford BC, Vacek JL, Emert MP, Hall WJ, Andrews ML, McNitt S, Zareba W, Moss AJ. Differences in outcomes between patients treated with single- versus dual-chamber implantable cardioverter defibrillators: a substudy of the Multicenter Automatic Defibrillator Implantation Trial II. Ann Noninvasive Electrocardiol 2005;10:429-35. [PMID: 16255753 DOI: 10.1111/j.1542-474X.2005.00063.x] [Cited by in Crossref: 22] [Article Influence: 1.5] [Reference Citation Analysis]
185 Suzuki T, Nazarian S, Jerosch-Herold M, Chugh SS. Imaging for assessment of sudden death risk: current role and future prospects. Europace 2016;18:1491-500. [PMID: 27098112 DOI: 10.1093/europace/euv456] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
186 Kadish AH, Bello D, Finn JP, Bonow RO, Schaechter A, Subacius H, Albert C, Daubert JP, Fonseca CG, Goldberger JJ. Rationale and design for the Defibrillators to Reduce Risk by Magnetic Resonance Imaging Evaluation (DETERMINE) trial. J Cardiovasc Electrophysiol. 2009;20:982-987. [PMID: 19493153 DOI: 10.1111/j.1540-8167.2009.01503.x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 45] [Article Influence: 6.8] [Reference Citation Analysis]
187 Choi HM, Park MS, Youn JC. Update on heart failure management and future directions. Korean J Intern Med. 2019;34:11-43. [PMID: 30612416 DOI: 10.3904/kjim.2018.428] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 10.7] [Reference Citation Analysis]
188 Al-Khatib SM, Hellkamp A, Bardy GH, Hammill S, Hall WJ, Mark DB, Anstrom KJ, Curtis J, Al-Khalidi H, Curtis LH, Heidenreich P, Peterson ED, Sanders G, Clapp-Channing N, Lee KL, Moss AJ. Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials. JAMA 2013;309:55-62. [PMID: 23280225 DOI: 10.1001/jama.2012.157182] [Cited by in Crossref: 70] [Cited by in F6Publishing: 44] [Article Influence: 8.8] [Reference Citation Analysis]
189 Hodgkinson KA, Parfrey PS, Bassett AS, Kupprion C, Drenckhahn J, Norman MW, Thierfelder L, Stuckless SN, Dicks EL, McKenna WJ. The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5). J Am Coll Cardiol. 2005;45:400-408. [PMID: 15680719 DOI: 10.1016/j.jacc.2004.08.068] [Cited by in Crossref: 126] [Cited by in F6Publishing: 78] [Article Influence: 7.9] [Reference Citation Analysis]
190 Stefanelli CB, Bradley DJ, Leroy S, Dick M 2nd, Serwer GA, Fischbach PS. Implantable cardioverter defibrillator therapy for life-threatening arrhythmias in young patients. J Interv Card Electrophysiol 2002;6:235-44. [PMID: 12154326 DOI: 10.1023/a:1019509803992] [Cited by in Crossref: 80] [Cited by in F6Publishing: 6] [Article Influence: 4.2] [Reference Citation Analysis]
191 Rudic B, Tülümen E, Liebe V, Kuschyk J, Akin I, Borggrefe M. [Sudden cardiac death : Epidemiology, pathophysiology and risk stratification]. Herz 2017;42:123-31. [PMID: 28229201 DOI: 10.1007/s00059-017-4545-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
192 Tate J, Stinstra J, Pilcher T, Poursaid A, Jolley MA, Saarel E, Triedman J, MacLeod RS. Measuring defibrillator surface potentials: The validation of a predictive defibrillation computer model. Comput Biol Med 2018;102:402-10. [PMID: 30195579 DOI: 10.1016/j.compbiomed.2018.08.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
193 Wilkoff BL, Stern R, Williamson B, Wathen M, Holloman K, Fieberg A, Brown M. Design of the Primary Prevention Parameters Evaluation (PREPARE) trial of implantable cardioverter defibrillators to reduce patient morbidity [NCT00279279]. Trials 2006;7:18. [PMID: 16725036 DOI: 10.1186/1745-6215-7-18] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
194 Kwok IB, Mather H, McKendrick K, Gelfman L, Hutchinson MD, Lampert RJ, Lipman HI, Matlock DD, Swetz KM, Kalman J, Pinney S, Morrison RS, Goldstein NE. Evaluation of a Novel Educational Intervention to Improve Conversations About Implantable Cardioverter-Defibrillators Management in Patients with Advanced Heart Failure. J Palliat Med 2020;23:1619-25. [PMID: 32609036 DOI: 10.1089/jpm.2020.0022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
195 Ajello L, Coppola G, Corrado E, La Franca E, Rotolo A, Assennato P. Diagnosis and treatment of asymptomatic left ventricular systolic dysfunction after myocardial infarction. ISRN Cardiol 2013;2013:731285. [PMID: 23577268 DOI: 10.1155/2013/731285] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
196 McLaughlin MG, Zimetbaum PJ. Electrocardiographic predictors of arrhythmic death. Ann Noninvasive Electrocardiol 2006;11:327-37. [PMID: 17040281 DOI: 10.1111/j.1542-474X.2006.00125.x] [Cited by in Crossref: 6] [Article Influence: 0.4] [Reference Citation Analysis]
197 Betensky BP, Marchlinski FE. Outcomes of Catheter Ablation of Ventricular Tachycardia in the Setting of Structural Heart Disease. Curr Cardiol Rep 2016;18:68. [PMID: 27234813 DOI: 10.1007/s11886-016-0742-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
198 Price JF, Jeewa A, Denfield SW. Clinical Characteristics and Treatment of Cardiomyopathies in Children. Curr Cardiol Rev 2016;12:85-98. [PMID: 26926296 DOI: 10.2174/1573403x12666160301115543] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
199 Cheema A, Singh T, Kanwar M, Chilukuri K, Maria V, Saleem F, Johnson K, Frank J, Pires L, Hassan S. Chronic kidney disease and mortality in implantable cardioverter-defibrillator recipients. Cardiol Res Pract 2010;2010:989261. [PMID: 20811610 DOI: 10.4061/2010/989261] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
200 Bauer A, Barthel P, Schneider R, Ulm K, Müller A, Joeinig A, Stich R, Kiviniemi A, Hnatkova K, Huikuri H, Schömig A, Malik M, Schmidt G. Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk). Eur Heart J 2009;30:576-83. [PMID: 19109245 DOI: 10.1093/eurheartj/ehn540] [Cited by in Crossref: 128] [Cited by in F6Publishing: 77] [Article Influence: 9.8] [Reference Citation Analysis]
201 McCauley MD, Vitale F, Yan JS, Young CC, Greet B, Orecchioni M, Perike S, Elgalad A, Coco JA, John M, Taylor DA, Sampaio LC, Delogu LG, Razavi M, Pasquali M. In Vivo Restoration of Myocardial Conduction With Carbon Nanotube Fibers. Circ Arrhythm Electrophysiol 2019;12:e007256. [PMID: 31401852 DOI: 10.1161/CIRCEP.119.007256] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
202 Al-Ahmad A, Wang PJ, Homoud MK, Estes NA 3rd, Link MS. Frequent ICD shocks due to double sensing in patients with bi-ventricular implantable cardioverter defibrillators. J Interv Card Electrophysiol 2003;9:377-81. [PMID: 14618060 DOI: 10.1023/a:1027455713120] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
203 Providência R, Marijon E, Lambiase PD, Bouzeman A, Defaye P, Klug D, Amet D, Perier MC, Gras D, Algalarrondo V, Deharo JC, Leclercq C, Fauchier L, Babuty D, Bordachar P, Sadoul N, Piot O, Boveda S. Primary Prevention Implantable Cardioverter Defibrillator (ICD) Therapy in Women-Data From a Multicenter French Registry. J Am Heart Assoc 2016;5:e002756. [PMID: 26873687 DOI: 10.1161/JAHA.115.002756] [Cited by in Crossref: 36] [Cited by in F6Publishing: 6] [Article Influence: 7.2] [Reference Citation Analysis]
204 Peretto G, Durante A, Limite LR, Cianflone D. Postoperative arrhythmias after cardiac surgery: incidence, risk factors, and therapeutic management. Cardiol Res Pract 2014;2014:615987. [PMID: 24511410 DOI: 10.1155/2014/615987] [Cited by in Crossref: 94] [Cited by in F6Publishing: 48] [Article Influence: 13.4] [Reference Citation Analysis]
205 Boriani G, Artale P, Biffi M, Martignani C, Frabetti L, Valzania C, Diemberger I, Ziacchi M, Bertini M, Rapezzi C, Parlapiano M, Branzi A. Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy. Heart Vessels 2007;22:184-92. [PMID: 17533523 DOI: 10.1007/s00380-006-0963-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
206 Chugh SS, Reinier K, Teodorescu C, Evanado A, Kehr E, Al Samara M, Mariani R, Gunson K, Jui J. Epidemiology of sudden cardiac death: clinical and research implications. Prog Cardiovasc Dis 2008;51:213-28. [PMID: 19026856 DOI: 10.1016/j.pcad.2008.06.003] [Cited by in Crossref: 406] [Cited by in F6Publishing: 290] [Article Influence: 31.2] [Reference Citation Analysis]
207 Clementy N, Bodin A, Bisson A, Teixeira-Gomes AP, Roger S, Angoulvant D, Labas V, Babuty D. The Defibrillation Conundrum: New Insights into the Mechanisms of Shock-Related Myocardial Injury Sustained from a Life-Saving Therapy. Int J Mol Sci 2021;22:5003. [PMID: 34066832 DOI: 10.3390/ijms22095003] [Reference Citation Analysis]
208 Theuns DA, Smith T, Hunink MG, Bardy GH, Jordaens L. Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis. Europace 2010;12:1564-70. [PMID: 20974768 DOI: 10.1093/europace/euq329] [Cited by in Crossref: 99] [Cited by in F6Publishing: 49] [Article Influence: 9.9] [Reference Citation Analysis]
209 Pellegrini CN, Lee K, Olgin JE, Turakhia MP, Tseng ZH, Lee R, Badhwar N, Lee B, Varosy PD. Impact of advanced age on survival in patients with implantable cardioverter defibrillators. Europace 2008;10:1296-301. [PMID: 18818212 DOI: 10.1093/europace/eun253] [Cited by in Crossref: 35] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
210 MacIntyre CJ, Sapp JL, Abdelwahab A, Al-Harbi M, Doucette S, Gray C, Gardner MJ, Parkash R. The Effect of Shock Burden on Heart Failure and Mortality. CJC Open 2019;1:161-7. [PMID: 32159102 DOI: 10.1016/j.cjco.2019.04.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
211 Bax JJ, Delgado V. Myocardial viability as integral part of the diagnostic and therapeutic approach to ischemic heart failure. J Nucl Cardiol 2015;22:229-45. [PMID: 25733105 DOI: 10.1007/s12350-015-0096-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
212 Winkle RA. The effectiveness and cost effectiveness of public-access defibrillation. Clin Cardiol 2010;33:396-9. [PMID: 20641115 DOI: 10.1002/clc.20790] [Cited by in Crossref: 32] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
213 Goldstein NE, Mehta D, Teitelbaum E, Bradley EH, Morrison RS. "It's like crossing a bridge" complexities preventing physicians from discussing deactivation of implantable defibrillators at the end of life. J Gen Intern Med 2008;23 Suppl 1:2-6. [PMID: 18095036 DOI: 10.1007/s11606-007-0237-x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 57] [Article Influence: 6.8] [Reference Citation Analysis]
214 Bansal N. Evolution of Cardiovascular Disease During the Transition to End-Stage Renal Disease. Semin Nephrol 2017;37:120-31. [PMID: 28410646 DOI: 10.1016/j.semnephrol.2016.12.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
215 Janaswamy P, Walters TE, Nazer B, Lee RJ. Current Treatment Strategies for Heart Failure: Role of Device Therapy and LV Reconstruction. Curr Treat Options Cardiovasc Med 2016;18:57. [PMID: 27488313 DOI: 10.1007/s11936-016-0479-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
216 Klingenheben T, Hohnloser SH. Usefulness of risk stratification for future cardiac events in infarct survivors with severely depressed versus near-normal left ventricular function: results from a prospective long-term follow-up study. Ann Noninvasive Electrocardiol 2003;8:68-74. [PMID: 12848816 DOI: 10.1046/j.1542-474x.2003.08111.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
217 Kunavarapu C, Bloomfield DM. Role of noninvasive studies in risk stratification for sudden cardiac death. Clin Cardiol 2004;27:192-7. [PMID: 15119692 DOI: 10.1002/clc.4960270404] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]